Arterial hypertension and cognitive impairment;Ipertensione arteriosa e deficit cognitivo

Annali Italiani di Medicina Interna

Volumn 19, Issue 3, 2004, Pages 163-170

  Paglieri, Cristina ^a   Bisbocci, Daniela ^a   Amenta, Francesco ^b   Veglio, Franco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Cerebrovascular disease; Cognitive functions; Dementia; Risk factors; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; COGNITIVE DEFECT; HUMAN; HYPERTENSION; MIDDLE AGED; REVIEW;

AGED; ANTIHYPERTENSIVE AGENTS; COGNITION DISORDERS; HUMANS; HYPERTENSION; MIDDLE AGED;

EID: 21644436229     PISSN: 03939340     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Birkenhäger WH, Forette F, Seux ML, Wang JG, Staessen JA. Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med 2001; 161: 152-6.
2. Forette F, Boller F. Hypertension and the risk of dementia in the elderly. Am J Med 1991; 90: 14S-19S.
3. Erkinjunti T. Cognitive decline and treatment options for patients with vascular dementia. Acta Neurol Scand 2002; 106: 15-8.
4. Cervilla JA, Prince M, Joels S, Lovestone S, Mann A. Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br J Psychiatry 2000; 177: 66-71.
5. Wentzel C, Rockwood K, MacKnight C, et al. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001; 57: 714-6.
6. Harrington F, Saxby BK, McKeith JG, Wesnes K, Ford GA. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000; 36: 1079-82.
7. Di Carlo A, Baldereschi M, Amaducci L, et al, and the ILSA Working Group. Stroke in an elderly population: incidence and impact on survival and daily function. The Italian Longitudinal Study on Aging. J Am Geriatr Soc 2002; 50: 41-8.
8. The systolic Hypertension in the Elderly Program Cooperative Research Group. Implications of the systolic hypertension in the elderly program. Hypertension 1993; 21: 335-43.
9. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee. Arch Intern Med 1997; 157: 2413-46.
10. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey 1988-1991. Hypertension 1995; 25: 305-13.
11. Evans D, Funkenstein H, Albert M, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989; 262: 2551-6.
12. Seux ML, Forette F. Effects of hypertension and its treatment on mental function. Curr Hypertens Rep 1999; 1: 232-7.
13. Farmer ME, Kittner SJ, Abbott RD, Wolz MM, Wolf PA, White LR. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. J Clin Epidemiol 1990; 43: 475-80.
14. Wong TY, Klein R, Sharrett R, et al. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons. The Atherosclerosis Risk in Communities Study. Stroke 2002; 33: 1487-92.
15. Miyao S, Takano A, Teramoto J, Takahashi A. Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke 1992; 23: 1434-8.
16. Van Swieten JC, Kappelle LJ, Algra A, van Latum JC, Koudstaal PJ, van Gijn J. Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Ann Neurol 1992; 32: 177-83.
17. Inzitari D, Di Carlo A, Mascalchi M, Pracucci G, Amaducci L. The cardiovascular outcome of patients with motor impairment and extensive leukoaraiosis. Arch Neurol 1995; 52: 687-91.
18. Dufouil C, Alpérovitch A, Tzourio C. Influence of education on the relationship between white matter lesions and cognition. Neurology 2003; 60: 831-6.
19. de Leeuw FE, de Kleine M, Frijns CJ, Fijnheer R, van Gijn J, Kappelle LJ. Endothelial cell activation is associated with cerebral white matter lesions in patients with cerebrovascular disease. Ann NY Acad Sci 2002; 977: 306-14.
20. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 1990; 16: 692-9.
21. Fukuda H, Kitani M. Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke 1995; 26: 1593-7.
22. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10: 875-8.
23. Kario K, Mtsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130-5.
24. Sierra C, de la Sierra A, Mercader J, Gòmez-Angelats E, Urbano-Màrquez A, Coca A. Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 2002; 20: 519-24.
25. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-22.
26. Shinkawa A, Ueda K, Kiyohara Y, et al. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke 1995; 26: 380-5.
27. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997; 28: 1932-9.
28. Swan GE, Decarli C, Mileer BL, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 1998; 51: 986-93.
29. Ballard C, O'Brien J, Morris CM, et al. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry 2001; 16: 499-503.
30. Sever PS, Dahlof B, Poulter NR, et al, for the ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149-58.
31. Shahar E, Chambless LE, Rosamond WD, et al. Plasma lipid profile and incident ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) study. Stroke 2003; 34: 623-31.
32. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 1975; 12: 189-98.
33. Magni E, Binetti G, Bianchetti A, Rozzini R, Trabucchi M. Minimental state examination: a normative study in Italian elderly population. Eur J Neurol 1996; 3: 1-5.
34. Clarke M, Jagger C, Anderson J, Battcock T, Kelly F, Stern MC. The prevalence of dementia in a total population: a comparison of two screening instruments. Age Ageing 1991; 20: 396-403.
35. Ostrosky-Solis F, Lopez-Arango G, Ardila A. Sensitivity and specificity of the mini-mental state examination in a Spanish-speaking population. Appl Neuropsychol 2000; 7: 25-31.
36. Manubens JM, Martinez-Lage P, Martinex-Lage JM, et al. Variation of mini-mental-state examination scores due to age and educational level. Normalized data in the population over 70 years of age in Pamplona. Neurologia 1998; 13: 111-9.
37. Heckbert SR, Longstreth WT, Psaty BM, et al. The association of antihypertensive agents with MRI white matter findings and with modified mini-mental state examination in older adults. J Am Geriatr Soc 1997; 45: 1423-33.
38. Launer LJ, Masaki K, Petrovich H, Foley D, Havlik RJ. The association between blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA 1995; 274: 1846-51.
39. Guo Z, Fratiglioni L, Winblad B, Vitanen M. Blood pressure and performance on the mini-mental state examination in the very old: cross-sectional and longitudinal data from the Kunsholmen Project. Am J Epidemiol 1997; 145: 1106-13.
40. Starr JM, Whalley LJ, Deary IJ. The effect of antihypertensive treatment on cognitive function: results from the HOPE Study. J Am Geriatr Soc 1996; 44: 411-5.
41. Lithell H, Hansson L, Skoog I, et al, for the SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind interventional trial. J Hypertens 2003; 21: 875-86.
42. Forette F, Seux ML, Staessen JA, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med 2002; 162: 2046-52.
43. Applegate WB, Pressel S, Wittes J. Impact of the treatment of isolated systolic hypertension on behavioral variables: results from the systolic hypertension in the Elderly Program. Arch Intern Med 1994; 154: 2154-60.
44. Goldstein G, Materson BJ, Cushman WC, Reda DJ, Freis ED, Ramirez EA. Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Hypertension 1990; 15: 361-9.
45. Cushman WC, Khatri I, Materson BJ, Reda DJ, Freis ED, Goldstein G. Treatment of hypertension in the elderly. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 1991; 151: 1954-60.
46. Amenta F, Mignini F, Rabbia F, Tomassoni D, Veglio F. Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data. J Neurol Sci 2002; 203-204: 147-51.
47. Breteler MM, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. BMJ 1994; 308: 1604-8.
48. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-41.
49. Tzourio C, Anderson C, Chapman N, et al, and the PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163: 1069-75.
50. Tedesco MA, Ratti G, Mannella S, et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am J Hypertens 1999; 12: 1130-4.
51. Fogari R, Mugellini A, Zoppi A, et al. Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J Hum Hypertens 2003; 17: 781-5.